You are here
In February 2016, RheumNow published 82 tweets about impactful news, research and teaching points that impact the rheumatology community. These feeds had a reach (impressions) of 80,800 with, 76 mentions, and over 2700 visits to learn on RheumNow.com. The average daily “tweet” from RheumNow is seen by 3000-8,000, with as many as 89,500 viewers for a single tweet. Our social media feeds are just one of several ways we deliver information to over 2500 rheumatologists and 2631 followers on Twitter. The following is a list of top tweets from January and February 2016; news items were selected based on the number of clicks, retweets and likes by the viewership.
- CDC issues a Zika Virus update: reviews those at risk and characteristic manifestations: acute fever, maculopapular rash, arthralgia, conjunctivitis, fetal loss, and microcephaly associated with pregnancy. http://buff.ly/20nSiOz This was published on 1/25/16 and had a reach of 89,500 viewers.
- JAMA Neurology publishes a population study showing that chronic use of proton pump inhibitors is associated with a higher risk of dementia. Unclear if this association is causal or casual. http://buff.ly/20Aoblb Published on 2/15/16 this post was viewed by 28,500.
- French guideline published on infection prevention in SLE; overall everyone needs influenza pneumococcal vaccination; avoid live virus vaccines, but no consensus on prophylaxis for pneumocystis. http://buff.ly/20VVm2O Published on 2/25/16, this report was viewed by 15,400.
- Posterior reversible encephalopathy syndrome (PRES) is a rare CNS manifestation in SLE. Risk is more common in younger patients and higher in those with hypertension, renal insufficiency, high disease activity, lymphopenia, and interestingly, hyperlipidemia. http://buff.ly/1Qn2iUZ This report was posted on 2/29/16 and was seen by 15,400.
- A blog on Ten Ways that RA could’ve killed famous Eagle - Glenn Frey. A major musical loss a reminder how behind we are in our management of RA. http://buff.ly/1Jrbxm4 Published on 1/23/16, it was seen by 14,700.
- The ocular manifestations of lupus are reviewed in BMJ. Microangiopathy is the most common finding, but optic neuritis is not common or associated with CNS lupus. http://buff.ly/1PvJ9hA This was published on 1/2/16 and viewed by 14600.
- FDA arthritis advisory committee reviewed a new biosimilar and voted 21-3 in favor of approving Celltrions’ CT-P13 (to be named Inflectra), a biosimilar of infliximab. http://buff.ly/1R1Cuwk This was posted on the day of the meeting, 2/9/16, and was viewed by 14,500.
- Nurses health study (>77000) review shows that chronic (4 – 10 yrs.) use of non-aspirin NSAIDs was associated with a significantly higher (34%) increased future risk of renal cell carcinoma. http://buff.ly/1OsevDr This was published on 1/14/16 and seen by 13100.
- Cohort review of IBD patients on Infliximab shows that drug induced skin manifestations are not uncommon (23%) and includes eczema and psoriasis like lesions - 41% these were exacerbations of underlying skin conditions. http://buff.ly/1Kk5K27 Published on 2/16/16, the report was seen by 12000.
- Metanalyses shows use of the influenza vaccine in lupus is safe; does not induce lupus flares and is moderately effective; although seroconversion rates are lower in lupus patients. http://buff.ly/1Q1MGEU This was posted on 2/24/16 and seen by 8900 viewers.